Finance

Lists
Outlook: 44.4% bullish·0.0% bearish
Go to analysis
PFIZ34:BVMF
Pfizer BDR
R$ 35.08
0.00%
(0.00) 1D
10-р сарын 8, 17:05:00 (GMT-3)  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for PFIZ34...
Mkt. cap
158.56Т
Avg. vol.
8.98 мян
Volume
0.00
52-wk high
R$ 37.70
52-wk low
R$ 30.09
Shares outstanding
5.70 тэрбум
No. of employees
75 мян
Mkt. cap
158.56Т
Avg. vol.
8.98 мян
Volume
0.00
52-wk high
R$ 37.70
52-wk low
R$ 30.09
Shares outstanding
5.70 тэрбум
No. of employees
75 мян
News stories
From web sources and news partners
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75 мян
Founded1849
HeadquartersНью-Йорк хот, Нью-Йорк Муж Улс, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websitepfizer.com
Last report
2026 оны 8-р сарын 4
Fiscal period
Q2 2026
EPS / Est. (USD)
$ 0.77 / $ 0.68
+12.87%beat
Revenue / Est. (USD)
15.03 тэрбум / 14.39 тэрбум
+4.49%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
16.65 тэрбум
17.56 тэрбум
14.45 тэрбум
15.03 тэрбум
Cost of goods sold
3.98 тэрбум
5.06 тэрбум
3.41 тэрбум
3.66 тэрбум
Cost of revenue
3.98 тэрбум
5.06 тэрбум
3.41 тэрбум
3.66 тэрбум
Research and development expenses
2.49 тэрбум
3.32 тэрбум
2.45 тэрбум
2.75 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.08 тэрбум
3.74 тэрбум
2.84 тэрбум
3.26 тэрбум
Operating expense
6.80 тэрбум
8.29 тэрбум
6.48 тэрбум
7.19 тэрбум
Total operating expenses
10.78 тэрбум
13.35 тэрбум
9.88 тэрбум
10.84 тэрбум
Operating income
5.88 тэрбум
4.20 тэрбум
4.57 тэрбум
4.19 тэрбум
Other non operating income
181.00 сая
1.35 тэрбум
36.00 сая
515.00 сая
EBT including unusual items
3.33 тэрбум
-1.64 тэрбум
3.17 тэрбум
-653.00 сая
EBT excluding unusual items
5.54 тэрбум
5.09 тэрбум
4.13 тэрбум
4.25 тэрбум
Income tax expense
-216.00 сая
-2.00 сая
461.00 сая
-407.00 сая
Effective tax rate
-6.48%
0.12%
14.55%
62.33%
Other operating expenses
-
-
-
-
Net income
3.54 тэрбум
-1.65 тэрбум
2.69 тэрбум
-248.00 сая
Net profit margin
21.26%
-9.39%
18.59%
-1.65%
Earnings per share
0.87
0.66
0.75
0.77
Interest and investment income
138.00 сая
247.00 сая
197.00 сая
211.00 сая
Interest expense
-652.00 сая
-711.00 сая
-668.00 сая
-667.00 сая
Net interest expenses
-514.00 сая
-464.00 сая
-471.00 сая
-456.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
7.53 тэрбум
5.86 тэрбум
6.18 тэрбум
5.80 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс